Adaptive Biotechnologies (ADPT) EPS (Weighted Average and Diluted) Growth (3y) (2023 - 2026)
Adaptive Biotechnologies (ADPT) EPS (Weighted Average and Diluted) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -33.24% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 10.09% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -4.22% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 10.81% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.57% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.71% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 21.28% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 251.69% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -0.55% |
| 10 | Adaptive Biotechnologies | 2.60 Bn | 2.39 Bn | 52.17 Mn | 31.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.25% |
| Dec 31, 2025 | 31.50% |
| Sep 30, 2025 | 29.81% |
| Jun 30, 2025 | 22.84% |
| Mar 31, 2025 | 23.11% |
| Dec 31, 2024 | 20.63% |
| Sep 30, 2024 | 18.07% |
| Jun 30, 2024 | 3.96% |
| Dec 31, 2023 | -12.22% |